AI assistant
Sending…
EyePoint Pharmaceuticals, Inc. — Director's Dealing 2021
Jun 23, 2021
32254_dirs_2021-06-23_4042f637-b5bf-4345-a4c9-c5b1b0fe948a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: EyePoint Pharmaceuticals, Inc. (EYPT)
CIK: 0001314102
Period of Report: 2021-06-22
Reporting Person: DICICCO WENDY F (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-06-22 | Restricted Stock Units | $0.00 | A | 2500.00 | Acquired | Common Stock (2500.00) | Direct | |
| 2021-06-22 | Stock Option (Right to Buy) | $13.13 | A | 11000.00 | Acquired | 2031-02-09 | Common Stock (11000.00) | Direct |
Footnotes
F1: Will fully vest on the one-year anniversary of the grant date.
More from EyePoint Pharmaceuticals, Inc.
Regulatory Filings
2026
May 14
Regulatory Filings
2026
May 6
Regulatory Filings
2026
Apr 13
Director's Dealing
2026
Mar 24
Regulatory Filings
2026
Mar 20
Regulatory Filings
2026
Mar 4
Regulatory Filings
2026
Mar 2
Director's Dealing
2026
Feb 18
Major Shareholding Notification
2026
Feb 12
Director's Dealing
2026
Jan 7